Finance

Lists
600351:SHA
Yabao Pharmaceutical Group Co Ltd
CNÂ¥6.82
+2.40%
(+0.16) 1D
Aug 7, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600351...
Open
CNÂ¥6.62
High
CNÂ¥6.82
Low
CNÂ¥6.57
Mkt. cap
4.68B
Avg. vol.
20.59M
Volume
36.39M
Dividend
5.13%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 15, 2026
P/E ratio
14.53
52-wk high
CNÂ¥7.97
52-wk low
CNÂ¥5.60
EPS
CNÂ¥0.47
Shares outstanding
787.04M
No. of employees
3K
Open
CNÂ¥6.62
High
CNÂ¥6.82
Low
CNÂ¥6.57
Mkt. cap
4.68B
Avg. vol.
20.59M
Volume
36.39M
Dividend
5.13%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 15, 2026
P/E ratio
14.53
52-wk high
CNÂ¥7.97
52-wk low
CNÂ¥5.60
EPS
CNÂ¥0.47
Shares outstanding
787.04M
No. of employees
3K
About Yabao Pharmaceutical Group Co Ltd
CEO-
Employees3.42K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websiteyabao.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
569.30M
531.35M
572.02M
572.92M
Cost of goods sold
265.23M
273.96M
267.45M
259.39M
Cost of revenue
265.23M
273.96M
267.45M
259.39M
Research and development expenses
23.75M
44.98M
18.35M
25.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
171.02M
181.71M
152.69M
176.72M
Operating expense
180.56M
261.05M
168.77M
205.98M
Total operating expenses
445.80M
535.01M
436.22M
465.37M
Operating income
123.51M
-3.66M
135.80M
107.55M
Other non operating income
-3.71M
7.73M
-156.73K
-613.69K
EBT including unusual items
40.93M
121.09M
124.75M
104.56M
EBT excluding unusual items
121.96M
77.27M
137.06M
107.45M
Income tax expense
17.63M
19.69M
17.78M
32.30M
Effective tax rate
43.07%
16.26%
14.25%
30.89%
Other operating expenses
-7.55M
24.39M
-1.97M
1.26M
Net income
40.70M
104.92M
106.66M
70.93M
Net profit margin
7.15%
19.75%
18.65%
12.38%
Earnings per share
-
-
-
-
Interest and investment income
2.20M
73.62M
1.61M
740.41K
Interest expense
-
-358.60K
-187.91K
-226.16K
Net interest expenses
2.20M
73.26M
1.42M
514.25K
Depreciation and amortization charges
-
-
-
-
EBITDA
157.50M
29.78M
169.23M
138.02M
Gain or loss from assets sale
50.19K
-182.99K
-
-1.53M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps